Keratinocyte transglutaminase in proliferative vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 11, 2006, Pages 4990-4997

  Priglinger, Siegfried G ^a   Alge, Claudia S ^a   Kreutzer, Thomas C ^a   Neubauer, Aljoscha S ^a   Haritoglou, Christos ^a   Kampik, Anselm ^a   Welge Luessen, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE TRANSGLUTAMINASE; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; IMMEDIATE EARLY PROTEIN; SIGNAL PEPTIDE; TRANSGLUTAMINASE 1;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; EVALUATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NORTHERN BLOTTING; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VITREORETINOPATHY; WESTERN BLOTTING; ADOLESCENT; ADULT; AGED; DRUG EFFECT; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PIGMENT EPITHELIUM;

ADOLESCENT; ADULT; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; PIGMENT EPITHELIUM OF EYE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA2; TRANSGLUTAMINASES; VITREORETINOPATHY, PROLIFERATIVE;

EID: 33947668703     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0273     Document Type: Article

References (62)

1. Glaser BM, Lemor M. Pathobiology of proliferative vitreoretinopathy. In: Ryan SJ, ed. The Retina 3. St. Louis, MO: Mosby-Year Book Press; 1994:2249-2263.
2. Kampik A, Kenyon KR, Michels RG, et al. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol. 1981;99:1445-1454.
3. Priglinger SG, May CA, Neubauer AS, et al. Tissue transglutaminase as a modifying enzyme of the extracellular matrix in PVR membranes. Invest Ophthalmol Vis Sci. 2003;44:355-364.
4. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
5. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991;5:3071-3077.
6. Lorand L, Conrad SM. Transglutaminases. Mol Cell Biochem. 1984;58:9-35.
7. Pisano JJ, Finlayson JS, Peyton MP. Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine. Science. 1968;160:892-893.
8. Fesus L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 1987;224:104-108.
9. Ho KC, Quarmby VE, French FS, Wilson EM. Molecular cloning of rat prostate transglutaminase complementary DNA: the major androgen-regulated protein DP1 of rat dorsal prostate and coagulating gland. J Biol Chem. 1992;267:12660-12667.
10. Lorand L, Hsu LK, Siefring GE Jr, Rafferty NS. Lens transglutaminase and cataract formation. Proc Natl Acad Sci USA. 1981;78:1356-1360.
11. Aeschlimann D, Mosher D, Paulsson M. Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin Thromb Hemost. 1996;22:437-443.
12. Hohl D. Cornified cell envelope. Dermatologica. 1990;180:201-211.
13. Rice RH, Green H. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell. 1977;11:417-422.
14. Hitomi K. Transglutaminases in skin epidermis. Eur J Dermatol. 2005;15:313-319.
15. Eckert RL, Sturniolo MT, Broome AM, et al. Transglutaminase function in epidermis. J Invest Dermatol. 2005;124:481-492.
16. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 1995;270:17702-17711.
17. Steinert PM, Kartasova T, Marekov LN. Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes. J Biol Chem. 1998;273:11758-11769.
18. Bernard BA, Asselineau D, Schaffar-Deshayes L, Darmon MY. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol. 1988;90:801-805.
19. Schroeder WT, Thacher SM, Stewart-Galetka S, et al. Type I keratinocyte transglutaminase: expression in human skin and psoriasis. J Invest Dermatol. 1992;99:27-34.
20. Thacher SM, Rice RH. Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell. 1985;40:685-695.
21. Matsuki M, Yamashita F, Ishida-Yamamoto A, et al. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci USA. 1998;95:1044-1049.
22. Nishida K, Yamanishi K, Yamada K, et al. Epithelial hyperproliferation and transglutaminase 1 gene expression in Stevens-Johnson syndrome conjunctiva. Am J Pathol. 1999;154:331-336.
23. Nakamura T, Nishida K, Dota A, et al. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci. 2001;42:549-556.
24. Zhao S, Rizzolo LJ, Barnstable CJ. Differentiation and transdifferentiation of the retinal pigment epithelium. Int Rev Cytol. 1997;171:225-266.
25. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
26. Machemer R. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment: the Proctor lecture. Invest Ophthalmol Vis Sci. 1988;29:1771-17783.
27. Alge CS, Suppmann S, Priglinger SG, et al. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci. 2003;44:3629-3641.
28. Hamel CP, Tsilou E, Pfeffer BA, et al. Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro. J Biol Chem. 1993;268:15751-15757.
29. Neill JM, Thornquist SC, Raymond MC, et al. RET-PE10: a 61 kD polypeptide epitope expressed late during vertebrate RPE maturation. Invest Ophthalmol Vis Sci. 1993;34:453-462.
30. Casaroli Marano RP, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2791-2803.
31. Hunt RC, Davis AA. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro. J Cell Physiol. 1990;145:187-199.
32. Grierson I, Hiscott PS, Hitchins C, et al. Which cells are involved in the formation of epiretinal membranes? Semin Ophthalmol. 1987;99-109.
33. Ando A, Ueda M, Uyama M, et al. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol. 2000;84:1306-1311.
34. Campochiaro PA, Jerdan JA, Glaser BM. Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol. 1984;102:1830-1833.
35. Campochiaro PA, Jerdon JA, Glaser BM. The extracellular matrix of human retinal pigment epithelial cells in vivo and its synthesis in vitro. Invest Ophthalmol Vis Sci. 1986;27:1615-1621.
36. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 1995;36:391-405.
37. Vinores SA, Derevjanik NL, Mahlow J, et al. Class III beta-tubulin in human retinal pigment epithelial cells in culture and in epiretinal membranes. Exp Eye Res. 1995;60:385-400.
38. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:839-846.
39. Ma JX, Zhang D, Laser M, et al. Identification of RPE65 in transformed kidney cells. FEBS Lett. 1999;452:199-204.
40. Welge-Lussen U, May CA, Lutjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol Vis Sci. 2000;41:2229-2238.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
42. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-498.
43. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001;15:188-200.
44. Grierson I, Hiscott P, Hogg P, et al. Development, repair and regeneration of the retinal pigment epithelium. Eye. 1994;8(pt 2):255-262.
45. Folk JE. Transglutaminases Annu Rev Biochem. 1980;49:517-531.
46. Cassidy L, Barry P, Shaw C, et al. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol. 1998;82:181-185.
47. Mitamura Y, Takeuchi S, Matsuda A, et al. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol. 2000;129:678-680.
48. Roberts AB, Sporn MB. The transforming growth factors βs. In: Sporn MB, Roberts AB, eds. Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors. Berlin: Springer; 1990:419-472.
49. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986;261:4337-4345.
50. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem. 1989;264:1860-1869.
51. Igarashi A, Bradham DM, Okochi H, Grotendorst GR. Connective tissue growth factor. J Dermatol. 1992;19:642-643.
52. Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 2003;81:355-363.
53. Meyer P, Wunderlich K, Kain HL, et al. Human connective tissue growth factor mRNA expression of epiretinal and subretinal fibrovascular membranes: a report of three cases. Ophthalmologica. 2002;216:284-291.
54. Fuchshofer R, Birke M, Welge-Lussen U, et al. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci. 2005;46:568-578.
55. Saunders NA, Jetten AM. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma: antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem. 1994;269:2016-2022.
56. Akimov SS, Krylov D, Fleischman LF, Belkin AM. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000;148:825-838.
57. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood. 2001;98:1567-1576.
58. Akimov SS, Belkin AM. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFβ-dependent matrix deposition. J Cell Sci. 2001;114:2989-3000.
59. Balklava Z, Verderio E, Collighan R, et al. Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem. 2002;277:16567-16575.
60. Jones RA, Nicholas B, Mian S, et al. Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci. 1997;110(pt 19):2461-2472.
61. Priglinger SG, Alge CS, Neubauer AS, et al. TGF-β2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin-binding domain. Invest Ophthalmol Vis Sci. 2004;45:955-963.
62. D'Argenio G, Calvani M, Della VN, et al. Differential expression of multiple transglutaminases in human colon: impaired keratinocyte transglutaminase expression in ulcerative colitis. Gut. 2005;54:496-502.